Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection

Clinical and Vaccine Immunology

Volumn 15, Issue 12, 2008, Pages 1780-1787

  Al Banna, Nadia ^a   Raghupathy, Raj ^a   Albert, M John ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; LUNG; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RANK SUM TEST; TH2 CELL;

ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MICE; MICE, INBRED BALB C; PNEUMONIA, BACTERIAL;

EID: 57349195165     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00193-08     Document Type: Article

References (60)

1. Abbas, A., and A. Lichtman. 2003. Cellular and molecular immunology, 5th ed. W. B. Saunders, Philadelphia, PA.
2. Abram, M., D. Vučković, B. Wraber, and M. Dorić. 2000. Plasma cytokine response in mice with bacterial infection. Mediators Inflamm. 9:229-234.
3. Al-Banna, N. A., T. A. Junaid, T. C. Mathew, R. Raghupathy, and M. J. Albert. 2008. Histopathological and ultrastructural studies of a mouse lung model of Campylobacter jejuni infection. J. Med. Microbiol. 57:210-217.
4. Al-Salloom, F. S., A. Al Mahmeed, A. Ismaeel, G. A. Botta, and M. Bakhiet. 2003. Campylobacter-stimulated INT 407 cells produce dissociated cytokine profiles. J. Infect. 47:217-224.
5. Bakhiet, M., F. S. Al-Salloom, A. Qareiballa, K. Bindayna, I. Farid, and G. A. Botta. 2004. Induction of α and β chemokines by intestinal epithelial cells stimulated with Campylobacter jejuni. J. Infect. 48:236-244.
6. Baqar, S., L. A. Applebee, and A. L. Bourgeois. 1995. Immunogenicity and protective efficacy of a prototype Campylobacter whole-cell vaccine in mice. Infect. Immun. 63:3731-3735.
7. Baqar, S., A. L. Bourgeois, L. A. Applebee, A. S. Mourad, M. T. Kleinosky, Z. Mohran, and J. R. Murphy. 1996. Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity. Infect. Immun. 64:4933-4939.
8. Baqar, S., N. D. Pacheco, and F. M. Rollwagen. 1993. Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob. Agents Chemother. 37:2688-2692.
9. Birkholz, S., U. Knipp, C. Nietzki, R. J. Adamek, and W. Opferkuch. 1993. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol. Med. Microbiol. 6:317-324.
10. Blaser, M. J. 1997. Epidemiologic and clinical features of Campylobacter jejuni infections. J. Infect. Dis. 176(Suppl.):S103- S105.
11. Chang, C., and J. F. Miller. 2006. Campylobacter jejuni colonization of mice with limited enteric flora. Infect. Immun. 74:5261-5271.
12. Chattopadhyay, U. K., R. S. Rathore, D. Pal, and M. S. Das. 1991. Enterotoxigenicity of human and animal isolates of Campylobacter jejuni in ligated rat ileal loops. J. Diarrhoeal Dis. Res. 9:20-22.
13. Clahsen, T., and F. Schaper. 2 September 2008, posting date. Interleukin-6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration. J. Leukoc. Biol. doi:10.1189/jlb.0308178. [Epub ahead of print.]
14. Diehl, S., and M. Rincon. 2002. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 39:531-536.
15. Enocksson, A., J. Lundberg, E. Weitzberg, A. Norrby-Teglund, and B. Svenungsson. 2004. Rectal nitric oxide gas and stool cytokine levels during the course of infectious gastroenteritis. Clin. Diagn. Lab. Immunol. 11:250-254.
16. Fernie, D. S., and R. W. Park. 1977. The isolation and nature of campylobacters (microaerophilic vibrios) from laboratory and wild rodents. J. Med. Microbiol. 10:325-329.
17. Field, L. H., J. L. Underwood, S. M. Payne, and L. J. Berry. 1991. Virulence of Campylobacter jejuni for chicken embryos is associated with decreased bloodstream clearance and resistance to phagocytosis. Infect. Immun. 59:1448-1456.
18. Fox, J. G., A. B. Rogers, M. T. Whary, Z. Ge, N. S. Taylor, S. Xu, B. H. Horwitz, and S. E. Erdman. 2004. Gastroenteritis in NF-κB-deficient mice is produced with wild-type Campylobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect. Immun. 72:1116-1125.
19. Fullner, K. J., J. C. Boucher, M. A. Hanes, G. K. Haines III, B. M. Meehan, C. Walchle, P. J. Sansonetti, and J. J. Mekalanos. 2002. The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J. Exp. Med. 195:1455-1462.
20. Haines, G. K., III, B. A. Sayed, M. S. Rohrer, V. Olivier, and K. J. Fullner Satchell. 2005. Role of Toll-Like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El Tor strains deficient in production of cholera toxin and accessory toxins. Infect. Immun. 73:6157-6164.
21. Henderson, B., S. Poole, and M. Wilson. 1998. Bacteria-cytokine interactions in health and disease. Portland Press, London, United Kingdom.
22. Hickey, T. E., S. Baqar, A. L. Bourgeois, C. P. Ewing, and P. Guerry. 1999. Campylobacter jejuni-stimulated secretion of interleukin-8 by INT 407 cells. Infect. Immun. 67:88-93.
23. Hickey, T. E., G. Majam, and P. Guerry. 2005. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytolethal distending toxin. Infect. Immun. 73:5194-5197.
24. Hu, L., and D. J. Kopecko. 2000. Interactions of Campylobacter with eukaryotic cells: gut luminal colonization and mucosal invasion mechanisms, p. 191-215. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter, 2nd ed. American Society for Microbiology Press, Washington, DC.
25. Hu, L., M. D. Bray, M. Osorio, and D. J. Kopecko. 2006. Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infect. Immun. 74:2697-2705.
26. Jones, M. A., S. Totemeyer, J. M. Duncan, C. E. Bryant, and P. A. Barrow. 2003. Induction of proinflammatory responses in human monocytic cell line THP-1 by Campylobacter jejuni. Infect. Immun. 71:2626-2633.
27. Jung, S., S. Zimmer, E. Lüneberg, M. Frosch, H. Karch, T. Korn, and K. V. Toyka. 2005. Lipooligosaccharide of Campylobacter jejuni prevents myelinspecific enteral tolerance to autoimmune neuritis - a potential mechanism in Guillain-Barré syndrome? Neurosci. Lett. 381:175-178.
28. Kamimura, D., K. Ishihara, and T. Hirano. 2003. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149:1-38.
29. Kidd, P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8:223-246.
30. Kiyono, H. 2001. Mucosal immune system: close encounter in the uncharted world of immunology. Ophthalmologica 215(Suppl. 1):22-32.
31. Korlath, J. A., M. T. Osterholm, L. A. Judy, J. C. Forfang, and R. A. Robinson. 1985. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J. Infect. Dis. 152:592-596.
32. Kum, W. W., S. B. Cameron, R. W. Hung, S. Kalyan, and A. W. Chow. 2001. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells. Infect. Immun. 69:7544-7549.
33. MacCallum, A. J., D. Harris, G. Haddock, and P. H. Everest. 2006. Campylobacter jejuni-infected human epithelial cell lines vary in their ability to secrete interleukin-8 compared to in vitro-infected primary human intestinal tissue. Microbiology 152:3661-3665.
34. Mansfield, L. S., J. A. Bell, D. L. Wilson, A. J. Murphy, H. M. Elsheikha, V. A. Rathinam, B. R. Fierro, J. E. Linz, and V. B. Young. 2007. C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis. Infect. Immun. 75:1099-1115.
35. Moran, A. 1995. Biological and serological characterization of Campylobacter jejuni lipopolysacharides with deviating core and lipid A structures. FEMS Immun. Med. Microbiol. 11:121-130.
36. Mulligan, M. S., M. L. Jones, A. A. Vaporciyan, M. C. Howard, and P. A. Ward. 1993. Protective effects of IL-4 and IL-10 against immune complexinduced lung injury. J. Immun. 151:5666-5674.
37. Newell, D. G. 2001. Animal models of Campylobacter jejuni colonization and disease and the lessons to be learned from similar Helicobacter pylori models. J. Appl. Microbiol. 90(Suppl.):57S- 67S.
38. Pancorbo, P. L., M. A. De Pablo, E. Ortega, A. M. Gallego, C. Alvarez, and G. A. De Cienfuegos. 1999. Evaluation of cytokine production and phagocytic activity in mice infected with Campylobacter jejuni. Curr. Microbiol. 39:129-133.
39. Pancorbo, P. L., M. A. De Pablo, E. Ortega, M. A. Puertollano, A. M. Gallego, and G. A. Cienfuegos. 2001. Potential intervention of Campylobacter jejuni in the modulation of murine immune response. Curr. Microbiol. 43:209-214.
40. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V. Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. Rajandream, K. M. Rutherford, A. H. van Vliet, S. Whitehead, and B. G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
41. Phalipon, A., M. Kaufmann, P. Michetti, J.-M. Cavaillon, M. Huerre, P. Sansonetti, and J.-P. Kraehenbuhl. 1995. Monoclonal immunoglobulin A antibody directed against serotype-specific of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J. Exp. Med. 182:769-778.
42. Prendergast, M. M., D. R. Tribble, S. Baqar, D. A. Scott, J. A. Ferris, R. I. Walker, and A. P. Moran. 2004. In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection. Infect. Immun. 72:916-922.
43. Raqib, B., A. A. Lindberg, B. Wretlind, P. K. Bardhan, U. Andersson, and J. Andersson. 1995. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect. Immun. 63:289-296.
44. Sestak, K., C. K. Merritt, J. Borda, E. Saylor, S. R. Schwamberger, F. Cogswell, E. S. Didier, P. J. Didier, G. Plauche, R. P. Bohm, P. P. Aye, P. Alexa, R. L. Ward, and A. A. Lackner. 2003. Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus monkeys. Infect. Immun. 71:4079-4086.
45. Siegesmund, A. M., M. E. Konkel, J. D. Klena, and P. F. Mixter. 2004. Campylobacter jejuni infection of differentiated THP-1 macrophages results in interleukin-1 release and caspase-1 independent apoptosis. Microbiology 150:561-569.
46. Skirrow, M. B., and M. J. Blaser. 1995. Campylobacter jejuni, p. 825-848. In M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, and R. L. Guerrant (ed.), Infections of the gastrointestinal tract. Raven Press, New York, NY.
47. Skirrow, M. B., and M. J. Blaser. 2000. Clinical aspects of Campylobacter infection, p. 69-88. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter, 2nd ed. American Society for Microbiology Press, Washington, DC.
48. Smith, G. S., and M. J. Blaser. 1985. Fatalities associated with Campylobacter jejuni infections. JAMA 253:2873-2875.
49. Strierter, R. M., T. J. Standiford, M. W. Rolfe, J. P. Lynch III, A. P. Metinko, and S. L. Kunkel. 1992. Cytokines in pulmonary injury, p. 397-412. In S. L. Kunkel and D. G. Remick (ed.), Cytokines in health and disease. Marcel Dekker, New York, NY.
50. Tauxe, R. V. 1992. Epidemiology of Campylobacter jejuni infections in the United States and other industralized nations, p. 9-19. In I. Nachamkin, M. J. Blaser, and L. S. Tompkins (ed.), Campylobacter jejuni: current status and future trends. American Society for Microbiology Press, Washington, DC.
51. Taylor, D. N. 1992. Campylobacter infections in developing countries, p. 20-30. In I. Nachamkin. M. J. Blaser, and L. S. Tompkins (ed.), Campylobacter jejuni: current status and future trends. American Society for Microbiology Press, Washington, DC.
52. Van De Verg, L. L., C. P. Mallett, H. H. Collins, T. Larsen, C. Hammack, and T. L. Hale. 1995. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. Infect. Immun. 63:1947-1954.
53. Van Vliet, A. H. M., and J. M. Ketley. 2001. Pathogenesis of enteric Campylobacter infection. J. Appl. Microbiol. 90(Suppl.): 45S-56S.
54. Vučković, D., M. Abram, M. Bubonja, B. Wraber, and M. Dorić. 2006. Host resistance to primary and secondary Campylobacter jejuni infections in C57BL/6 mice. Microb. Pathog. 40:35-39.
55. Vučković, D., M. Abram, and M. Dorić. 1998. Primary Campylobacter jejuni infection in different mice strains. Microb. Pathog. 24:263-268.
56. Wang, J., J. Wakeham, R. Harkness, and Z. Xing. 1999. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J. Clin. Investig. 103:1023-1029.
57. Warren, J. S., K. R. Yabroff, D. G. Remick, S. L. Kunkel, S. W. Chensue, R. G. Kunkel, K. J. Johnson, and P. A. Ward. 1989. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Investig. 84:1873-1882.
58. Watson, R. O., V. Novik, D. Hofreuter, M. Lara-Tejero, and J. E. Galán. 2007. A MyD88-deficient mouse model reveals a role for Nramp1 in Campylobacter jejuni infection. Infect. Immun. 75:1994-2003.
59. Xing, Z., J. Gauldie, G. Cox, H. Baumann, M. Jordana, X. F. Lei, and M. K. Achong. 1998. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Investig. 101:311-320.
60. Yuki, N. 1997. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller-Fisher syndrome. J. Infect. Dis. 176(Suppl.):S150-S153.